학술논문
Interim results for the Phase 1/2 PRISM Trial evaluating 4D-150, a dual-transgene intravitreal genetic medicine in individuals with neovascular (wet) age-related macular degeneration
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15525783